Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Ann Nucl Med

Retrieve available abstracts of 105 articles:
HTML format
Text format



Single Articles


    November 2016
  1. CHO SG, Park KS, Kim J, Kang SR, et al
    Coronary flow reserve and relative flow reserve measured by N-13 ammonia PET for characterization of coronary artery disease.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  2. METSER U, Halankar J, Langer D, Mohan R, et al
    Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  3. ELISEI F, Crivellaro C, Giuliani D, Dolci C, et al
    Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  4. ISHIWATA K, Hayashi K, Sakai M, Kawauchi S, et al
    Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    September 2016
  5. URANO M, Maki Y, Nishikawa H, Kawai T, et al
    Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  6. SHANDIZ MS, Rad HS, Ghafarian P, Karam MB, et al
    MR-guided attenuation map for prostate PET-MRI: an intensity and morphologic-based segmentation approach for generating a five-class attenuation map in pelvic region.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  7. HOSHIKAWA H, Mori T, Maeda Y, Takahashi S, et al
    Influence of volumetric 4'-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  8. YOO J, Yoon HJ, Kim BS
    Prognostic value of primary tumor SUVmax on F-18 FDG PET/CT compared with semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  9. CARRIO I, Kinuya S
    New section in EJNMMI and Annals of Nuclear Medicine.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  10. KIM J, Lee JO, Paik JH, Lee WW, et al
    Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  11. SHIMOSEGAWA E, Isohashi K, Naka S, Horitsugi G, et al
    Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  12. CHOI WH, Um YH, Jung WS, Kim SH, et al
    Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  13. SUZAWA N, Ichikawa Y, Ishida M, Tomita Y, et al
    Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  14. SHIBUTANI T, Onoguchi M, Katafuchi T, Kinuya S, et al
    Development of a myocardial phantom and analysis system toward the standardization of myocardial SPECT image across institutions.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  15. SAKATANI T, Shimoo S, Takamatsu K, Kyodo A, et al
    Usefulness of the novel risk estimation software, Heart Risk View, for the prediction of cardiac events in patients with normal myocardial perfusion SPECT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  16. IBARAKI M, Matsubara K, Sato K, Mizuta T, et al
    Validation of a simplified scatter correction method for 3D brain PET with 15O.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  17. SHIBA H, Takahashi A, Baba S, Himuro K, et al
    Analysis of the influence of 111In on 90Y-bremsstrahlung SPECT based on Monte Carlo simulation.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  18. HUANG YE, Huang YJ, Ko M, Hsu CC, et al
    Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  19. KURISU S, Sumimoto Y, Ikenaga H, Watanabe N, et al
    Effects of left ventricular size on the accuracy of diastolic parameters derived from myocardial perfusion SPECT: comparison with tissue Doppler echocardiography.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  20. HELALI M, Addeo P, Heimburger C, Detour J, et al
    Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  21. NONOKUMA M, Kuwabara Y, Hida K, Tani T, et al
    Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  22. KONDO A, Ishii H, Aoki S, Suzuki M, et al
    Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  23. LEE SH, Jin S, Lee HS, Ryu JS, et al
    Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  24. PARK SB, Choi JY, Kim HJ, Kim HJ, et al
    Incidental focal 18F-FDG uptake in the frontal process of the maxilla on PET/CT: prevalence and clinical significance.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  25. IDOLAZZI L, Salgarello M, Gatti D, Viapiana O, et al
    Erratum to: 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  26. ARIMOTO MK, Higashi T, Nishii R, Kagawa S, et al
    11C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with 18F-fluorodeoxyglucose PET.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  27. TOYOHARA J, Sakata M, Hatano K, Yanai S, et al
    Preclinical and first-in-man studies of [11C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  28. HAN EJ, Park HL, Lee YS, Park EK, et al
    Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  29. TERADA T, Yokokura M, Yoshikawa E, Futatsubashi M, et al
    Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  30. JEONG YJ, Son HJ, Yoon HJ, Kang DY, et al
    Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson's disease and normal subjects.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  31. ZOGHI M, Jalilian AR, Niazi A, Johari-Daha F, et al
    Erratum to: Development of a Ga-peptide tracer for PET GnRH1-imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  32. NOBASHI T, Nakamoto Y, Kubo T, Ishimori T, et al
    The utility of PET/CT with Ga-DOTATOC in sarcoidosis: comparison with Ga-scintigraphy.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  33. LEE JJ, Chung JH, Kim SY
    Effect of F-fluorodeoxyglucose extravasation on time taken for tumoral uptake to reach a plateau: animal and clinical PET analyses.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  34. ANNUNZIATA S, Cuccaro A, Calcagni ML, Hohaus S, et al
    Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  35. HIDA K, Nonokuma M, Kuwabara Y, Tani T, et al
    Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  36. PATHAK KA, Klonisch T, Nason RW, Leslie WD, et al
    FDG-PET characteristics of Hurthle cell and follicular adenomas.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  37. FUJITA W, Matsunari I, Aoki H, Nekolla SG, et al
    Prediction of all-cause death using C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  38. VON EYBEN FE, Kairemo K
    Acquisition with C-choline and F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  39. WATANABE H, Ishii K, Hosono M, Imabayashi E, et al
    Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  40. LUCA I, Matteo S, Davide G, Ombretta V, et al
    18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  41. IIZUKA T, Kameyama M
    Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  42. ZOGHI M, Jalilian AR, Niazi A, Johari-Daha F, et al
    Development of a Ga-peptide tracer for PET GnRH1-imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    March 2016
  43. SHIGEMOTO Y, Suga K, Matsunaga N
    F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  44. TAKESHITA T, Morita K, Tsutsui Y, Kidera D, et al
    The influence of respiratory motion on the cumulative SUV-volume histogram and fractal analyses of intratumoral heterogeneity in PET/CT imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  45. HWANG HS, Han YM, Choi YJ, Koh SH, et al
    Visual and quantitative comparison of F-fluorodeoxyglucose PET/CT findings in the detection of pelvic tumor recurrence in colorectal cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  46. NAKAJIMA K, Matsumoto N, Kasai T, Matsuo S, et al
    Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  47. LEE HS, Oh JS, Park YS, Jang SJ, et al
    Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via F-FDG PET/CT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  48. VERGER A, Yagdigul Y, Van Der Gucht A, Poussier S, et al
    Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  49. LIM SM, Kim H, Kang B, Kim HS, et al
    Prognostic value of F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  50. LI P, Liu Q, Wang C, Wang T, et al
    Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  51. TANAKA K, Yamamoto Y, Maeda Y, Yamamoto H, et al
    Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Ann Nucl Med. 2016;30:89-96.
    PubMed     Text format     Abstract available


    January 2016
  52. KERAMIDA G, Hunter J, Dizdarevic S, Peters AM, et al
    Heterogeneity of intrahepatic fat distribution determined by F-FDG PET and CT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  53. DE LUCA S, Fonti R, Camera L, Salvatore B, et al
    Multimodal imaging with F-FDG-PET/CT and In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  54. KOBAYASHI M, Matsunari I, Nishi K, Mizutani A, et al
    Simultaneous acquisition of Tc- and I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  55. MITOMO O
    Quantification of nonuniform distribution of hemi-lung perfusion in chronic obstructive pulmonary disease.
    Ann Nucl Med. 2016;30:3-10.
    PubMed     Text format     Abstract available


  56. CHIEN KJ, Huang HW, Huang TC, Lee CL, et al
    Assessment of branch pulmonary artery stenosis in children after repair of tetralogy of Fallot using lung perfusion scintigraphy comparison with echocardiography.
    Ann Nucl Med. 2016;30:49-59.
    PubMed     Text format     Abstract available


  57. HARATA N, Yoshida K, Oota S, Fujii H, et al
    (18)F-FDG uptake of the spinal cord was decreased after conventional dose radiotherapy in esophageal cancer patients.
    Ann Nucl Med. 2016;30:35-9.
    PubMed     Text format     Abstract available


  58. SOYDAL C, Kucuk ON, Bilgic S, Ibis E, et al
    Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Ann Nucl Med. 2016;30:29-34.
    PubMed     Text format     Abstract available


    December 2015
  59. JAILLARD A, Baillet C, Beron A, Tabibzadeh N, et al
    FDG PET/CT allowing detection and follow-up of tumor cell transplantation.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  60. ISHII S, Shimao D, Hara T, Miyajima M, et al
    Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  61. SAGA T, Inubushi M, Koizumi M, Yoshikawa K, et al
    Prognostic value of PET/CT with F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  62. RAYAMAJHI SJ, Mittal BR, Maturu VN, Agarwal R, et al
    F-FDG and F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  63. KINUYA S
    30th anniversary of Annals of Nuclear Medicine.
    Ann Nucl Med. 2015.
    PubMed     Text format    


  64. KOOPMAN D, van Dalen JA, Stigt JA, Slump CH, et al
    Current generation time-of-flight F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  65. KREMER R, Peysakhovich Y, Dan LF, Guralnik L, et al
    FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  66. FALLAHI B, Esmaeili A, Beiki D, Oveisgharan S, et al
    Evaluation of Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  67. KITAMURA Y, Kozaka T, Miwa D, Uno I, et al
    Synthesis and evaluation of a new vesamicol analog o-[C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  68. YAMAMOTO Y, Tasaki Y, Kuwada Y, Ozawa Y, et al
    A preliminary report of breast cancer screening by positron emission mammography.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  69. KIM HJ, Cho A, Yun M, Kim YT, et al
    Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  70. KIDERA D, Kihara K, Akamatsu G, Mikasa S, et al
    The edge artifact in the point-spread function-based PET reconstruction at different sphere-to-background ratios of radioactivity.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    October 2015
  71. PARK SY, Lee SJ, Yoon JK
    The prognostic value of total lesion glycolysis via F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  72. MAEBATAKE A, Akamatsu G, Miwa K, Tsutsui Y, et al
    Relationship between the image quality and noise-equivalent count in time-of-flight positron emission tomography.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  73. KOJIMA A, Gotoh K, Shimamoto M, Hasegawa K, et al
    Iodine-131 imaging using 284 keV photons with a small animal CZT-SPECT system dedicated to low-medium-energy photon detection.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  74. SHINTAWATI R, Achmad A, Higuchi T, Shimada H, et al
    Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  75. ITO R, Iwano S, Kishimoto M, Ito S, et al
    Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  76. AKAMATSU G, Ikari Y, Nishio T, Nishida H, et al
    Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  77. NODA Y, Goshima S, Kanematsu M, Watanabe H, et al
    F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    August 2015
  78. TAKAMURA T, Horiguchi Y, Kanna M, Matsushita H, et al
    Validation of prone myocardial perfusion SPECT with a variable-focus collimator versus supine myocardial perfusion SPECT with or without computed tomography-derived attenuation correction.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  79. ROWE SP, Gorin MA, Hammers HJ, Som Javadi M, et al
    Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted F-DCFPyL PET/CT.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  80. DI BIAGIO D, Chiaravalloti A, Tavolozza M, Abbatiello P, et al
    Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early F-FCH PET/CT?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  81. SHIMIZU K, Okita R, Saisho S, Yukawa T, et al
    Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  82. WITHOFS N, Charlier E, Simoni P, Alvarez-Miezentseva V, et al
    F-FPRGD PET/CT imaging of musculoskeletal disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  83. YI C, Yu D, Shi X, He Q, et al
    Biodistribution and estimation of radiation-absorbed doses in humans for N-ammonia PET.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  84. PETERS MJ, Wierts R, Jutten EM, Halders SG, et al
    Evaluation of a short dynamic F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  85. HOU PN, Tsai SC, Lin WY, Cheng CM, et al
    Relationship of quantitative parameters of myocardial perfusion SPECT and ventricular arrhythmia in patients receiving cardiac resynchronization therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  86. TANAKA T, Shinya T, Sato S, Mitsuhashi T, et al
    Predicting pleural invasion using HRCT and F-FDG PET/CT in lung adenocarcinoma with pleural contact.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  87. IKOMA Y, Sasaki T, Kimura Y, Seki C, et al
    Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with F-FE-PE2I.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  88. SUZUKI A, Takeuchi W, Ishitsu T, Morimoto Y, et al
    High-resolution brain SPECT imaging by combination of parallel and tilted detector heads.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  89. YAMAMOTO T, Kadoya N, Shirata Y, Kaneta T, et al
    Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  90. KOIZUMI M, Miyaji N, Murata T, Motegi K, et al
    Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  91. SENDA M, Yamamoto Y, Sasaki M, Yamane T, et al
    An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.
    Ann Nucl Med. 2015;29:391-9.
    PubMed     Text format     Abstract available


  92. SOYDAL C, Keskin O, Kucuk ON, Ozkan E, et al
    Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy.
    Ann Nucl Med. 2015;29:426-30.
    PubMed     Text format     Abstract available


    May 2015
  93. ISHINO S, Miyake H, Vincent P, Mori I, et al
    Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  94. HOCAZADE C, Ozdemir N, Yazici O, Bozkaya Y, et al
    Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  95. MATSUTOMO N, Nagaki A, Yamao F, Sasaki M, et al
    Optimization of iterative reconstruction parameters with 3-dimensional resolution recovery, scatter and attenuation correction in I-FP-CIT SPECT.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  96. APOSTOLOPOULOS DJ, Kaspiri A, Spyridonidis T, Patsouras N, et al
    Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  97. OGINO Y, Horiguchi Y, Ueda T, Shiomori T, et al
    A myocardial perfusion imaging system using a multifocal collimator for detecting coronary artery disease: validation with invasive coronary angiography.
    Ann Nucl Med. 2015;29:366-70.
    PubMed     Text format     Abstract available


  98. OKUYUCU K, Kavakli K, Ozaydin S, Karahatay S, et al
    Parathyroid adenoma upstaging the lung cancer.
    Ann Nucl Med. 2015;29:371-4.
    PubMed     Text format     Abstract available


    April 2015
  99. STACY MR, Paeng JC, Sinusas AJ
    The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis.
    Ann Nucl Med. 2015;29:217-23.
    PubMed     Text format     Abstract available


  100. DOROUDI A, Erfani M, Norouzi B, Saadati SM, et al
    Clinical application of ultrasound for preparation of (99m)Tc-sestamibi complex.
    Ann Nucl Med. 2015;29:295-301.
    PubMed     Text format     Abstract available


    February 2015
  101. AKTAS A, Kocabas B, Erhamamci S, Gencoglu A, et al
    Cardiac blood pool activity on postablation radioiodine imaging.
    Ann Nucl Med. 2015;29:170-6.
    PubMed     Text format     Abstract available


    January 2015
  102. KUSMIEREK J, Pietrzak-Stelmasiak E, Bienkiewicz M, Woznicki W, et al
    Diagnostic efficacy of parametric clearance images in detection of renal scars in children with recurrent urinary tract infections.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  103. DE QUEIROS AS, Brandao SC, Macedo LG, Ourem MS, et al
    Evaluation of normality and reproducibility parameters of scintigraphy with (99m)Tc-MAA in the diagnosis of intrapulmonary vascular dilatations.
    Ann Nucl Med. 2015;29:46-51.
    PubMed     Text format     Abstract available


  104. BAJC M, Markstad H, Jarenback L, Tufvesson E, et al
    Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.
    Ann Nucl Med. 2015;29:91-9.
    PubMed     Text format     Abstract available


    November 2014
  105. BATS AS, Frati A, Froissart M, Orliaguet I, et al
    Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study.
    Ann Nucl Med. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: